Mechanisms associated with mitochondrial-generated reactive oxygen species in cancer

Meghan L Verschoor1, Leigh A Wilson, Gurmit Singh

  • 1Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON L8N 3Z5, Canada.

Insights

Mitochondria communicate with the nucleus using reactive oxygen species (ROS). Cancer cells exploit altered mitochondrial ROS signaling for enhanced proliferation and survival, often upregulating aggressive cancer factors like Ets-1.

Area of Science:

  • Cell Biology
  • Cancer Biology
  • Mitochondrial Biology

Background:

  • Mitochondria possess their own genome and contribute to cellular respiration.
  • Mitochondria communicate with the nucleus via reactive oxygen species (ROS).
  • Mitochondrial function and signaling are often altered in cancer cells.

Purpose of the Study:

  • To investigate the role of mitochondrial signaling, specifically ROS, in cancer.
  • To understand how altered mitochondrial ROS impacts cancer cell proliferation and survival.
  • To explore the transcriptional changes induced by mitochondrial ROS in cancer.

Main Methods:

  • Analysis of mitochondrial genome and function in cancer cells.
  • Detection and quantification of ROS production.
  • Assessing the impact of ROS on signaling pathways (e.g., MAPK) and transcription factors (e.g., AP-1, NF-kappaB, p53, HIF-1alpha, Ets-1).

Main Results:

  • Mitochondria in cancer cells exhibit altered genomes and functional characteristics, leading to increased glycolysis.
  • ROS produced by mitochondria act as signaling molecules, inhibiting MAPK phosphatases and promoting cancer cell proliferation and survival.
  • ROS influence transcription factors, leading to altered gene expression, including upregulation of Ets-1, associated with aggressive cancers.

Conclusions:

  • Altered mitochondrial ROS signaling is a key mechanism supporting cancer cell growth and survival.
  • Mitochondrial dysfunction in cancer contributes to a pro-tumorigenic signaling environment.
  • Targeting mitochondrial ROS pathways may offer novel therapeutic strategies for aggressive cancers.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Electron Transport Chain: Complex III and IV01:43

Electron Transport Chain: Complex III and IV

During the electron transport chain, electrons from NADH and FADH2 are first transferred to complexes I and II, respectively. These two complexes then transfer the electrons to ubiquinol, which carries them further to complex III. Complex III passes the electrons across the intermembrane space to Cyt c, which carries them further to complex IV. Complex IV donates electrons to oxygen and reduces it to water. As electrons pass through complexes I, III, and IV, the energy released aids the pumping...